Clinical updates, including trial initiations, enrollment status and data readouts and publications: Accuray, Anaconda Biomed, Aseptiscope, Bionano Genomics, Kurin, Neovasc, Nevro.

Med-tech firms raising money in public or private financings, including: Ace Vision Group, Ecential Robotics, Endo Tools Therapeutics, Predictive Oncology, Senseonics.

New hires and promotions in the med-tech industry, including: Alma, Artificial, Bioventus, CHF Solutions, Foundation Medicine, Sophia Genetics, Zimmer Biomet.

The latest global regulatory news, changes and updates affecting biopharma.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Bioinvent, C4, Dr. Reddy's, Genmab, Gracell, Immunitybio, Khondrion, Metacrine, Molecular Templates, Omeros, Pieris, Precision, Steba, Takeda, Tessa, Tracon, Transgene.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aavnergene, Advaxis, Aptinyx, Boehringer Ingelheim, Brickbio, Capricor, Cocrystal, Conserv, Cure Genetics, Elsalys, Etana, Everest, Faron, Gritstone, Hanmi, Immunitybio, Innovent, Intravacc, Invixa, Janssen, Lipigon, Merck & Co., Minerva, Miragen, Neucyte, Neurogene, Neurophth, Novadiscovery, Oncosec, Orchard, OS Therapies, Oxford, Propanc, Provention, Royalty, Secarna, Spero, Syntekabio, Tenax, Tennor, Twist, Vigeneron, Viridian.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aclaris, Agios, Algernon, Bausch + Lomb, Bioeclipse, Biohaven, Biophytis, Brickell, Caladrius, Debiopharm, Evgen, Genkyotex, Grifols, Incarda, Lixte, Phathom, Sernova, Servier, Sinomab, Sirnaomics, Vallon, Verrica.

Biopharmas raising money in public or private financings, including: Athira, Beam, Biophytis, Covicept, Enveric, Neurobo, Slate, TCR2, Theratechnologies, Vera, Vero.

New hires and promotions in the biopharma industry, including: Applied Molecular Transport, Antibiotic Research UK, Atea, Avrobio, Awakn, Beximco, Chiasma, Evolve, Evox, Frequency, Imago, Kite, Mersana, Neximmune, ONK, ONL, Receptor, RDIF, Sophia Genetics, Swanbio, Tarsus, Viridian, Xbiotech.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CMS wraps up prior authorization rule; ITC finds no violation of Section 337.